The Future of Longevity Medicine Starts Here

Longevity medicine is expanding beyond biological age, biomarkers, and emerging technology. In this special episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald shares four thought-provoking conversations exploring the science, clinical tools, and deeply human questions shaping the future of healthspan.

</p>

Dr. Dale Bredesen and Dr. Kat Toups discuss preliminary findings from their six-site randomized controlled trial evaluating a personalized precision medicine approach to cognitive decline, including changes in cognitive performance, neuroplasticity, and Alzheimer’s-related biomarkers.

</p>

Peter Diamandis explores AI, exponential technologies, and the future of medicine—while considering whether technological advances could ever replace the foundational role of diet, movement, sleep, and lifestyle.

</p>

Dr. Aviva Romm examines the evolving understanding of PCOS, reproductive health as a vital sign, and the metabolic, hormonal, inflammatory, environmental, and psychosocial factors influencing women’s health across the lifespan.

</p>

Stanford-trained physician and public health advocate Dr. Casey Means joins Dr. Fitzgerald for a thought-provoking reflection on what it means to be human. She also speaks on pregnancy, birth, public scrutiny, health beyond biomarkers, and the roles of equanimity, stewardship, connection, and meaning in a well-lived life.

</p>

Join Dr. Kara Fitzgerald and more than 30 leading clinicians, researchers, and educators for the free Functional Medicine IS Longevity Medicine Masterclass, live September 18–19, 2026. Register here: https://functionalmedicineislongevitymedicine.com

</p>